• Gurgude Harshada Nanasaheb
• Damodar ankita
• Gaikar mayur

The aim of this investigation was to assess the antidiabetic properties of Anti-Diabetic Churna using the streptozotocin-induced diabetes model, as well as its alpha amylase and alpha glucosidase inhibitory activities.[1] One of particularly prevalent metabolic diseases, diabetes mellitus affecting 2.8% of people worldwide and is projected to reach 5.4% by 2025. Herbal remedies have long been regarded as an extremely valuable form of medicine; as a result, they are increasingly featured in cutting-edge, contemporary care. Consequently, based on the review Medicinal plants’ ability to lower blood glucose levels is mostly ascribed to the presence of polyphenols, flavonoids, terpenoids, coumarins, and other components. Antidiabetic churna – a compound ayurvedic preparation made up of Pterocarpus marsupium, Azardirachta indica, ocimum sanctum, syzygium cumini, trigonella foenum graceum, emblica officinalis, glycyrrhiza glabra, curcuma longa, black salt, piper nigrum, zingiber officinalis was screened for its antidiabetic activities.[2] Churna was subjected to in vitro antidiabetic screening using the starch iodine and dinitro salicylic acid (DNSA) methods, which involved α-amylase inhibition and IC 50 value was calculated.[3] The powder characteristics performed like Ash value, Angle of repose, Density, bulk density, tapped density, LOD, pH of churna. The standard limits have been surpassed for each parameter

Churna, alpha amylase, alpha glucosidase, metabolic disease, diabetes mellitus, herbal remedies, lower blood glucose, IC50

"Formulation and Evaluation of ANTI-DIABETIC churna ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.11, Issue 4, page no.p170-p186, April-2024, Available :http://www.jetir.org/papers/JETIR2404G23.pdf

"Formulation and Evaluation of ANTI-DIABETIC churna ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.11, Issue 4, page no. ppp170-p186, April-2024, Available at : http://www.jetir.org/papers/JETIR2404G23.pdf